Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cervarix PMS in Healthy Filipino Females
NCT00730847Phase 4Terminated
- Sponsor
- GSK
- Start
- Sep 2008
- Primary completion
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen in human papillomavirus infection, sponsored by GSK. Started Sep 2008; status: terminated.
02
Drugs
Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT00730847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730847.